The Cancer Letter 12.09.16 The Parker Institute for Cancer Immunotherapy and the Cancer Research Institute announced a collaboration focused on neoantigens Read
FiercePharma 12.06.16 Parker Institute, Cancer Research Institute team up on neoantigen-based cancer vaccines Read
FierceBiotech 12.01.16 Sean Parker’s I/O group teams up with CRI for cancer neoantigens R&D deal Read
TechCrunch 12.01.16 Sean Parker is partnering with the Cancer Research Institute to find a cancer vaccine Read
San Francisco Business Times 12.01.16 Sean Parker’s big push to hack cancer takes aim at tumor ‘tags’ Read
The CenterWatch Weekly 11.28.16 Parker Institute’s IRB Reliance Agreement signals a new phase in the trend toward consolidation Read
ASCO Post 11.25.16 The Emergence of Philanthropy to Fund High-Risk, High-Reward Cancer Research A Conversation With Jeffrey Bluestone, PhD Read
WebMD 11.15.16 Parker Institute for Cancer Immunotherapy Featured in “The Cutting Edge of Cancer with Robin Roberts” Read